Award for leading Spanish ophthalmologist

Article

Dr Jorge Alio, a valued member of Ophthalmology Times Europe?s Editorial Advisory Board, has been acknowledged by The Cornea Research Foundation of America (CRFA) for his technique using Yag laser treatments to eliminate epithelial ingrowth after Lasik.

Dr Jorge Alió, a valued member of Ophthalmology Times Europe’s Editorial Advisory Board, has been acknowledged by The Cornea Research Foundation of America (CRFA) for his technique using Yag laser treatments to eliminate epithelial ingrowth after Lasik.

The Torchbearer Award, presented to Dr Alió, during the ESCRS meeting in Barcelona recognizes individuals whose lifetime service and commitment to the field of vision care has helped light the way for others. It was developed by CRFA Founder Dr Francis W. Price, Jr., MD to recognize dedicated ophthalmic research physicians throughout the world.

The award was made for Dr Alió's work on the development of a non-invasive method to treat glare and halos post laser surgery. According to the CRFA, Epithelial cells rarely grow into the interface between the Lasik flap and underlying stromal bed after primary procedures. However, after re-treatments, where Lasik flaps are lifted and replaced, epithelial ingrowth can occur in up to 5-10% of cases. Dr Alió's innovative treatment creates a dramatic improvement in this condition. Previously flaps had to be re-lifted to remove the cells. The epithelial ingrowth could recur after its removal, and in some cases the Lasik flaps would require suturing down to prevent the epithelial cells from returning. Now with the use of the YAG laser, there are no more flap lifts or sutures to correct this condition providing better outcomes and more comfortable treatments for patients.

To learn more about the Foundation visit www.cornea.org

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.